Search
-
GLP–1s: A Healthcare Revolution?
One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.
-
Mastering complexity: The path towards a cancer-free reality
This is the third and final paper in a series which began eight years ago, focusing on unravelling – and ultimately overcoming – the sheer complexity of cancer, one of humanity’s oldest and most formidable foes.
-
Innovation Areas in In-Vitro Diagnostics
Today, leaders and pioneers in IVD are partnering with Ipsos to accelerate advancements across several key innovation areas
-
[Webinar] Alternative Funding Models for High-Cost Innovative Drugs - Thailand & APAC
This webinar is jointly hosted by Chulabhorn Royal Academy and Ipsos Singapore
-
Alternative Funding Models for High-Cost Innovative Drugs in Thailand – A Roadmap towards an Implementation
Identifying alternative funding models (MEAs and dedicated funds) to improve innovative medicines access for oncology and rare diseases in Thailand
-
Covid-positive experience changes outlook on life for many Singaporeans
52% Singaporeans say being positive with COVID-19 changed their outlook on life. and other findings from recent study.
-
Conquering Complexity: The ongoing revolution in oncology biomarker testing
The clinical management of cancer patients has undergone a remarkable evolution in the last 15 years, with the concept of personalised medicine now well-entrenched in the treatment paradigm.